Glenmede Trust’s Ventyx Biosciences VTYX Stock Holding History

Glenmede Trust’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-42,055	Closed	-$380K	–	1546
2025 Q4	$380K	Buy	+42,055	New	+$314K	﹤0.01%	1043
2023 Q1	–	Sell	-10,390	Closed	-$341K	–	1349
2022 Q4	$341K	Buy	+10,390	New	+$308K	﹤0.01%	949

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust's VTYX Position: Q1 2026 in Review

Glenmede Trust sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 42,055 shares — an estimated $380K sold.

Glenmede Trust first reported a position in VTYX in Q4 2022 and held it in 2 quarters. The position peaked at $380K in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Glenmede Trust reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Glenmede Trust sold 42,055 Ventyx Biosciences shares in Q1 2026, an estimated $380K.
Glenmede Trust first reported a position in Ventyx Biosciences in Q4 2022 and held it in 2 quarters.
Glenmede Trust's Ventyx Biosciences position peaked at $380K in Q4 2025.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.